UNSPSC 51111752: Menogaril

This classification denotes an anthracycline antibiotic with the molecular formula C28H31NO10, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 8JSV4O30HQ, chemically known as 2,6-epoxy-2h-naphthaceno(1,2-b)oxocin-9,16-dione, 4-(dimethylamino)-3,4,5,6,11,12,13,14-octahydro-3,5,8,10,13-pentahydroxy-11-methoxy-6,13-dimethyl-, (2r-(2alpha,3beta,4alpha,5beta,6alpha,11alpha,13alpha))- but generally known as menogaril, which bears US NIH Compound Identifier 51370.

UNSPSC 51111752 Menogaril is a Commodity code under which state and local governments procure pharmaceutical products and medical supplies, though recent solicitations show a broader scope than the code name alone suggests — jurisdictions are buying naloxone, safe drug deactivation systems, generic multi-source pharmaceuticals and OTC products, and medical and first aid supplies for emergency response and health program support. The issuing bodies span state health and human services agencies, county health departments, city emergency services, and cooperative purchasing alliances representing multiple state and local jurisdictions. Work solicited under this code ranges from point-of-use supplies for fire rescue divisions to bulk pharmaceutical procurement through authorized wholesale channels, and from direct-to-manufacturer prescription initiatives to standard bid-discount acquisitions for certified small local businesses.

Recent activity is concentrated in Florida and Minnesota, with broader multistate reach through cooperative vehicles. The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), administered by the Minnesota Department of Administration, posted an RFP on January 20, 2026 (due March 26, 2026) for generic multi-source pharmaceuticals and OTC products serving participating state and local facilities across Minnesota and Oregon, evaluated on price competitiveness (75 percent weight), fixed pricing (10 percent), EDI capability (5 percent), and administrative compliance (5 and 5 percent). Seminole County, Florida issued an IFB on June 30, 2026 (due July 26, 2023) for 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries to the county health building. The City of Tampa's Purchasing Department posted an ITB on March 25, 2026 (due March 13, 2026) for 169 line items of medical and first aid supplies for the Fire Department Rescue Division, with an estimated contract value of $700,000.00 and exclusive small local business enterprise (SLBE) set-aside with a 5 percent bid discount up to $10,000. The Texas Health and Human Services Commission issued an RFI on April 3, 2026 to gather vendor capabilities on direct-to-manufacturer prescription fulfillment outside traditional PBM and GPO arrangements.